(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

IMMODULON

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

IMMODULON

ST13

US500000088354623

Classe

5, 42, 44

Pedido

88354623

Registro

6564939

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

38

Atualização mais recente

29/04/2022

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 42, 44

Data de depósito

25/03/2019

Data de registro

23/11/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

23/11/2021

Última transação

29/04/2022

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use

Código do desenho

4

Tipo de titular

99

Localização do titular

London, GB

Examinador

MIZELLE HOWARD, DEZMONA

Unidade examinadora

M10

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Immodulon Therapeutics Limited

Representantes

Alexandra MacKay STITES & HARBISON, PLLC

Classificação técnica

Classes Nice

Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Vaccines; immune modulatorspharmaceutical preparations for treatment of immune system related diseasesdisordersdysregulation; vitamins and vitamin preparations

Classe 42

Scientific and technological services and research and design relating theretoresearch and development in the pharmaceutical and biotechnology fields; scientific and industrial analysis and research servicesresearch relating to immune system related diseases and disorders; clinical research in the field of medical sciencemedical and scientific research in the nature of conducting clinical trials; research and development services in the fields of drug discoverydrug discovery productspharmaceuticalsmedicinal diagnosticsbiological productsmedical apparatusdevices and instrumentspharmaceutical drug development services; supply of information in the area of laboratory technologyproviding technology information in the medical diagnostic industry; medical laboratory services; provision of scientific information via Internet portalsproviding scientific information regarding immunotherapy products in the nature of pharmaceutical preparations for the treatment of immune system related diseasedisorderdysregulation; scientific consultancyconsulting services in the field of the research and development of immunotherapy productspharmaceutical preparations for the treatment of immune system related diseasedisorderdysregulation; consultancy and research in the fields of science and technologyresearch in the pharmaceutical and biotechnology fields; laboratory analysis and diagnostic serviceslaboratory services in the nature of analysis and diagnosis of immune dysregulation; technical consultation and research in the fields of biotechnology and drug discovery; product research and development; providing databases in the fields of science and technologyproviding an on-line computer database in the field of medical and scientific research of immune dysregulation

Classe 44

Medical and therapeutic servicestreatment of patients with immuno disorders; medicalhygienic and beauty care for human beings; provision of medical information; advisory services relating to medical servicespreparations and apparatusproviding medical informationconsultancy and advisory services; providing information and advice in the field of healthcare; providing databases and information in the field of healthproviding an on-line computer database featuring information regarding health and nutrition

Publicações

Histórico de despachos e eventos da marca no USPTO.

38 publicações encontradas

R.PR

REGISTERED-PRINCIPAL REGISTER

23/11/2021

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

19/10/2021

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

19/10/2021

IUCN

NOTICE OF ALLOWANCE CANCELLED

05/10/2021

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

05/10/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

04/05/2021

EX1G

SOU EXTENSION 1 GRANTED

30/04/2021

EXT1

SOU EXTENSION 1 FILED

30/04/2021

EEXT

SOU TEAS EXTENSION RECEIVED

30/04/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

10/11/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

15/09/2020

PUBO

PUBLISHED FOR OPPOSITION

15/09/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

26/08/2020

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

12/08/2020

ALIE

ASSIGNED TO LIE

05/08/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/08/2020

DMCC

DATA MODIFICATION COMPLETED

03/08/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/07/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/07/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

30/07/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/02/2020

GNRT

NON-FINAL ACTION E-MAILED

05/02/2020

CNRT

NON-FINAL ACTION WRITTEN

05/02/2020

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

31/01/2020

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

06/12/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/12/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

25/11/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

23/11/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

23/11/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/06/2019

GNRT

NON-FINAL ACTION E-MAILED

10/06/2019

CNRT

NON-FINAL ACTION WRITTEN

10/06/2019

DOCK

ASSIGNED TO EXAMINER

05/06/2019

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

06/05/2019

ALIE

ASSIGNED TO LIE

06/05/2019

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

27/04/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/04/2019

NWAP

NEW APPLICATION ENTERED

28/03/2019

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace IMMODULON ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.